On the 19th February 2014, CALC ran the fourth annual PSI careers event. Fifteen different companies and organisations descended on the University of Sheffield, along with approximately 90 BSc, MSc and PhD students from across the country for a half-day event which consisted of a mix of presentations, newly created workshops, and time for the students to talk to the different companies.
The companies included a mix of pharmaceutical companies and CROs (Adelphi Values, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, GSK, PAREXEL, Phastar, PhUSE, PPD, PRA, PSI, Quanticate, Roche, and Veramed). The representatives talked to students about the industry: the opportunities open to them, and their personal experiences of work in the industry to date. In addition, representatives from five universities (Lancaster, Leicester, LSHTM, Reading, and Sheffield) joined to advertise the various course options open to students should they be interested in further study.
The presentation topics for the day included an introduction to the pharmaceutical industry, a discussion of the differences between a statistician and a statistical programmer, the current trends and future challenges seen in the industry, and the role of outcomes research in the industry. In addition, we had a presentation from a new starter in the industry to give the students a real feel for what they could be doing in the next year or so. We also had a session called ‘Statisticians on the spot’: five volunteers were literally put on the spot and asked some fairly difficult questions! This ‘Mock the week’ style session was much more informal and hopefully showed statisticians in a different light.
Feedback received shows that both the companies and the students found the day extremely useful, and that this was our most popular event yet. The students particularly enjoyed hearing experiences in the ‘Statisticians on the spot’ session, and speaking to the company representatives. Many students would have liked even longer time to speak to the companies, which we plan to address for next year’s event.
PSI CALC hopes to repeat the success of the event again next year. The location and timing of the event is currently under discussion, so watch this space for more details later in the year! - See more at: http://www.psiweb.org/careers/careers#sthash.GqIgMSge.dpuf
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Webinar: Development of Gene Therapies: Strategic, Scientific, Regulatory and Access Considerations
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Statisticians in the Pharmaceutical Industry Executive Office: c/o MCI UK Ltd | Unit 24/22 South | Building 4000 | Langstone Park| Langstone Road | Havant | PO9 1SA | UK